New hope for advanced bladder cancer: experimental drug takes on chemo in major trial
NCT ID NCT06857175
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study tests a new drug called BL-B01D1 against standard chemotherapy for people with advanced bladder cancer (urothelial carcinoma) that has worsened after prior treatments. About 508 adults whose cancer did not respond to platinum chemo and immunotherapy will be randomly assigned to receive either BL-B01D1 or a doctor-chosen chemo. The goal is to see if the new drug helps people live longer or delays cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Conditions
Explore the condition pages connected to this study.